Resolution of chiral drugs by liquid chromatography based upon diastereomer formation with chiral derivatization reagents.
about
Validated high-performance liquid chromatographic enantioseparation of selenomethionine using isothiocyanate based chiral derivatizing reagents.Chiral drugs: an overview.High-performance liquid chromatographic enantioseparation of (RS)-bupropion using isothiocyanate-based chiral derivatizing reagents.Resolution of enantiomers of bupropion and its metabolites by liquid chromatography.(RS)-Propranolol: enantioseparation by HPLC using newly synthesized (S)-levofloxacin-based reagent, absolute configuration of diastereomers and recovery of native enantiomers by detagging.Liquid chromatographic enantioseparation of three beta-adrenolytics using new derivatizing reagents synthesized from (S)-ketoprofen and confirmation of configuration of diastereomers.Enantioresolution of (RS)-baclofen by liquid chromatography: A review.Enantiomeric fraction as an indicator of pharmaceutical biotransformation during wastewater treatment and in the environment--a review.Synthesis of single-enantiomer bioactive molecules: a brief overview.Direct and indirect high-performance liquid chromatography enantioseparation of trans-4-hydroxy-2-nonenoic acid.Use of chiral derivatization for the determination of dichlorprop in tea samples by ultra performance LC with fluorescence detection.Chiral Separation of Ormeloxifene Hydrochloride, a Non-steroidal Contraceptive Agent.Significance and challenges of stereoselectivity assessing methods in drug metabolism.Development and Validation of a Normal Phase Chiral HPLC Method for Analysis of Afoxolaner Using a Chiralpak® AD-3 Column.Simultaneous Quantitative Determination of Synthetic Cathinone Enantiomers in Urine and Plasma Using GC-NCI-MS.Zirconia-Based Stationary Phases for Chiral Separation: Mini Review
P2860
Q34005711-0691DCF0-88D2-43DC-85B0-8BB3D578953BQ34344756-242C6F2D-F61D-4892-9D6B-C0D5CFD13CE0Q34647263-6292B9DD-347F-42F2-9EFC-17416A143D7DQ35731310-D83B835D-E708-41A0-A3A8-E673E93DE24EQ35872964-FEAB642B-368D-4215-A8B3-F2C0C73FDBBCQ36003646-1EB36C49-CFAC-4ABF-BDC5-D05D89AF2565Q36122484-77A57714-3C0B-4F35-9BEA-69E3EDEC0D59Q37814345-689C7BBB-C00F-4C96-ACBB-894F40692317Q38171439-EC182D02-DF63-41DE-AB5D-26F99A127FF5Q42043333-405CF8DC-09EB-4FD8-AA56-7BB28FF4AFF3Q43624444-62BFCB13-69E3-44B1-8D1C-19BF83906DA4Q48968181-9E242C33-41CC-4D63-BF8F-5D54E9A2281AQ49538988-F10E9929-4D46-49BF-AFD3-12CAB3EA104AQ52860342-56E034F4-67CC-4D33-86A4-918E02ABDFF9Q55189863-9C8D5E28-9A66-482F-A669-85A837F54AB0Q58299011-5D0CCE2B-C36A-46EB-B7C9-76FB11D904A1
P2860
Resolution of chiral drugs by liquid chromatography based upon diastereomer formation with chiral derivatization reagents.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resolution of chiral drugs by ...... hiral derivatization reagents.
@ast
Resolution of chiral drugs by ...... hiral derivatization reagents.
@en
type
label
Resolution of chiral drugs by ...... hiral derivatization reagents.
@ast
Resolution of chiral drugs by ...... hiral derivatization reagents.
@en
prefLabel
Resolution of chiral drugs by ...... hiral derivatization reagents.
@ast
Resolution of chiral drugs by ...... hiral derivatization reagents.
@en
P1476
Resolution of chiral drugs by ...... hiral derivatization reagents.
@en
P2093
Toshimasa Toyo'oka
P356
10.1016/S0165-022X(02)00127-6
P577
2002-12-01T00:00:00Z